Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
isentress
Medication labelWhy this: Advisory · dailymed-prescription
ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age and older. The use of other active agents with ISENTRESS is associated with a greater likelihood of treatment response [see CLINICAL STUDIES (14)].
- generic_name
- isentress
- product_names
- ISENTRESS
- ndc
- 67296-1235, 0006-0227, 67296-1235-8, 67296-1235-6, 67296-1235-7
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en